|1.||Luo, Yongzhang: 12 articles (11/2015 - 01/2006)|
|2.||Pihlajaniemi, Taina: 12 articles (08/2015 - 04/2002)|
|3.||Yang, Li: 12 articles (01/2014 - 05/2004)|
|4.||Folkman, Judah: 12 articles (06/2012 - 09/2002)|
|5.||Ramakrishnan, S: 11 articles (08/2011 - 04/2000)|
|6.||Fu, Yan: 10 articles (11/2015 - 10/2007)|
|7.||Heljasvaara, Ritva: 9 articles (08/2015 - 06/2003)|
|8.||Huang, Wenlin: 9 articles (06/2014 - 08/2005)|
|9.||Wang, Wei: 8 articles (01/2015 - 03/2005)|
|10.||Li, Kai: 8 articles (08/2013 - 08/2005)|
01/01/2014 - "Endostatin is a potent anti-angiogenesis compound with efficacy in treating solid tumors and other diseases. "
02/01/2013 - "Furthermore, Ad-TERT p-E1 demonstrated significantly superior oncolytic effects in the RB mouse model, and Ad-endostatin effectively suppressed tumor growth and extended the overall lifespan of subjects; however, the Ad-E2F1 p-E1A was clearly less effective in attaining these goals. "
07/01/2000 - "A phase I trial of Endostatin which will evaluate the safety and efficacy of Endostatin at a range of doses in no more than 100 cancer patients has been initiated. "
08/01/2011 - "Addition of an integrin-targeting moiety, R-G-D, resulted in better localization to tumor vasculature and improved the antiangiogenic activity of endostatin. "
09/08/2009 - "Endostatin has been demonstrated to represent a promising novel medicine to treat malignant tumors, and it may be more effective when combined with conventional treatment. "
|2.||Neoplasm Metastasis (Metastasis)
01/01/2010 - "Median endostatin concentration was significantly higher in patients with distant metastases than in patients with remission (141.95 v. 105.345 ng/ml, p < 0.05). "
04/01/2003 - "Patients with distant metastasis (n = 7) had significantly greater levels of endostatin and MMP-9 than patients without metastasis (n = 45) (endostatin 69.8 ng/mL versus 43.3 ng/mL, P <0.001; MMP-9 1529 ng/mL versus 674 ng/mL, P <0.001). "
01/01/2010 - "Although median serum endostatin levels are higher in patients with distant metastases than in patients with remission, its clinical usefulness is limited due to the overlapping data between the study groups. "
11/01/2011 - "Antiangiogenic therapy with endostatin is effective in inhibiting the postoperative progression of distant metastasis."
01/01/2010 - "We provided a cross-sectional analysis of the study group divided into patients with distant and/or locoregional metastases and patients with remission, and compared it with serum endostatin levels of healthy volunteers. "
|3.||Melanoma (Melanoma, Malignant)
07/01/2013 - "However, efficacy of recombinant human endostatin (rhES) in clinical trials is controversial, and application of rhES in treatment of metastatic melanoma awaits further investigations. "
12/01/2005 - "To study the biological characteristics of human endostatin (hEndo) gene transfected adult skin melanoma cells in vitro and in vivo. "
01/01/2010 - "Similar melanoma growth inhibition was obtained for mice treated with encapsulated or non-encapsulated endostatin-expressing cells. "
06/01/2007 - "Endostatin plus interferon-alpha2b therapy for metastatic melanoma: a novel combination of antiangiogenic and immunomodulatory agents."
05/01/2007 - "Peritoneal administration of encapsulated endostatin-CHO cells inhibited melanoma growth to 66.4% and enhanced the survival of treated mice to 80% by 27 days posttreatment. "
|4.||Colorectal Neoplasms (Colorectal Cancer)
10/14/2014 - "Serum endostatin levels are elevated in colorectal cancer and correlate with invasion and systemic inflammatory markers."
01/01/2014 - "Suppression of peritoneal tumorigenesis by placenta-derived mesenchymal stem cells expressing endostatin on colorectal cancer."
08/01/2011 - "In conclusion, our results suggest that endostatin reduces colorectal tumor-induced lymphangiogenesis, at least in part, by inhibiting EDA-integrin α9 pathway."
08/01/2011 - "To test this hypothesis, we examined the effect of endostatin on EDA secreted by SW480 colorectal cancer cells and treated human LECs with different doses of endostatin in the presence of conditional medium from SW480 cells. "
08/01/2011 - "Since it is known that EDA interacts with integrin α9 in the lymphatic endothelial cells (LECs), we hypothesized that endostatin may target EDA-integrin α9 pathway to inhibit colorectal tumor-induced lymphangiogenesis. "
|5.||Lewis Lung Carcinoma
11/01/2001 - "Immune response against 3LL Lewis lung carcinoma potentiates the therapeutic efficacy of endostatin."
10/01/2005 - "The kinetics of endostatin expression and efficacy of the pXLG-mEndo and radiation ((60)Co gamma-rays) combination was evaluated in the C57BL/6 mouse-Lewis lung carcinoma (LLC) model. "
04/01/2005 - "In the present study, a unique plasmid vector for the mouse endostatin gene, pXLG-mEndo, was constructed and evaluated with and without radiation using the Lewis lung carcinoma (LLC) cell line. "
11/01/2001 - "The antitumor effects of endostatin were tested against weakly immunogenic 3LL Lewis lung carcinoma and its highly immunogenic variant 3LL-C75. "
04/25/2000 - "In addition, the endostatin vector treatment completely prevented the formation of pulmonary micrometastases in Lewis lung carcinoma (P = 0.0001). "
|2.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|4.||Proteins (Proteins, Gene)
|5.||Collagen Type XVIII (Type XVIII Collagen)
|10.||Messenger RNA (mRNA)
|1.||Heterologous Transplantation (Xenotransplantation)
|2.||Drug Therapy (Chemotherapy)